How should I manage a non‑diabetic adult with persistent 2‑3+ ketonuria, normal blood glucose, normal anion gap, mild metabolic acidosis, hypertension, secondary Raynaud's phenomenon, and livedo reticularis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Non-Diabetic Persistent Ketonuria with Normal Anion Gap and Systemic Vascular Features

This patient requires urgent investigation for an underlying systemic disorder causing both metabolic derangement and vascular manifestations—the combination of persistent 2-3+ ketonuria with normal anion gap, mild acidosis, hypertension, Raynaud's phenomenon, and livedo reticularis suggests a complex pathophysiologic process beyond simple starvation ketosis.

Key Diagnostic Distinction

The clinical presentation does NOT fit typical diabetic ketoacidosis (DKA) or starvation ketosis patterns described in guidelines 1, 2, 3. Standard DKA criteria require blood glucose >250 mg/dL, pH <7.3, bicarbonate <15 mEq/L, and anion gap >10 1, 3. Your patient has:

  • Normal glucose (excluding DKA)
  • Normal to low-normal anion gap (5-10, excluding typical DKA)
  • Mild acidosis only (CO2 21-28, bicarbonate likely 21-28 range)
  • Persistent ketonuria despite normal eating

Starvation ketosis typically produces bicarbonate ≥18 mEq/L and does not cause severe systemic manifestations 2, 3. The vascular features (severe hypertension, secondary Raynaud's, livedo reticularis) indicate this is NOT simple starvation ketosis 4.

Immediate Workup Algorithm

1. Exclude Occult Causes of Ketosis

  • Measure serum β-hydroxybutyrate directly (not just urine ketones)—the nitroprusside method used for urine dipstick only detects acetoacetate and acetone, missing β-hydroxybutyrate, the predominant ketone body 1, 3, 1
  • Serum lactate (to exclude type B lactic acidosis with normal anion gap)
  • Comprehensive metabolic panel with calculated osmolar gap
  • Toxicology screen including salicylates, methanol, ethylene glycol 2, 1

2. Investigate Systemic Vascular Disease

The triad of hypertension + Raynaud's + livedo reticularis demands evaluation for:

  • Antiphospholipid syndrome (anticardiolipin antibodies, lupus anticoagulant, anti-β2-glycoprotein I)
  • Systemic lupus erythematosus (ANA, anti-dsDNA, complement levels)
  • Vasculitis panel (ANCA, cryoglobulins)
  • Thrombotic microangiopathy markers (LDH, haptoglobin, peripheral smear, ADAMTS13 if indicated)

3. Assess for Medication/Drug-Induced Causes

  • Recent SGLT2 inhibitor use (can cause euglycemic ketoacidosis) 5, 6
  • Glucocorticoid therapy 7, 8
  • Sympathomimetic agents 3

4. Evaluate Renal Tubular Function

Normal anion gap metabolic acidosis with ketonuria raises concern for:

  • Renal tubular acidosis (urine pH, urine anion gap, fractional excretion of bicarbonate) 9
  • Proximal RTA can cause bicarbonate wasting with secondary ketosis
  • Check urine chloride to differentiate chloride-responsive vs chloride-resistant causes 10, 9

Management Strategy

Acute Phase

  1. Fluid resuscitation if volume depleted—isotonic saline 15-20 mL/kg/h initially 2, 3

  2. Electrolyte monitoring every 2-4 hours, particularly:

    • Potassium (supplement to maintain >3.3 mEq/L before any insulin) 1, 2
    • Chloride and bicarbonate trends
    • Phosphate if <1.0 mg/dL 1
  3. DO NOT routinely give insulin unless glucose rises or true DKA develops—this patient's normal glucose with ketosis suggests insulin is NOT the primary issue 1, 2

  4. DO NOT give bicarbonate unless pH <6.9—studies show no benefit for pH >7.0 and potential harm 1, 7

Hypertension Management

  • Target BP 130-140/80-90 mmHg acutely (avoid aggressive lowering that could worsen perfusion)
  • Consider ACE inhibitor or ARB if renal function stable 11
  • Avoid diuretics initially until volume status clarified

Monitoring Protocol

  • Venous blood gases every 2-4 hours (arterial not necessary) 1, 3, 1
  • Serum electrolytes, glucose, BUN, creatinine every 2-4 hours 1, 3
  • Continuous cardiac monitoring if severe acidosis or electrolyte abnormalities
  • Urine output monitoring

Critical Pitfalls to Avoid

  1. Do not assume this is DKA based solely on ketonuria—the normal glucose and normal anion gap exclude typical DKA 1, 2, 3

  2. Do not rely on urine ketone dipsticks to monitor response—they measure acetoacetate, not β-hydroxybutyrate, and can paradoxically worsen during treatment as β-hydroxybutyrate converts to acetoacetate 1, 3, 1

  3. Do not use eGFR equations to assess renal function in this acute setting—they are inaccurate during metabolic derangement; use timed urine creatinine clearance if needed 12

  4. Do not overlook the vascular manifestations—the combination with metabolic acidosis suggests systemic disease requiring rheumatologic/hematologic evaluation, not just metabolic management

Subspecialty Consultation

  • Nephrology for persistent acidosis, abnormal anion gap, and possible RTA 12
  • Rheumatology for evaluation of Raynaud's, livedo reticularis, and possible autoimmune disease
  • Endocrinology if occult diabetes or unusual metabolic disorder suspected

The normal anion gap with persistent ketonuria distinguishes this from typical high anion gap ketoacidosis and demands investigation for renal tubular dysfunction, systemic inflammatory/autoimmune disease, or medication effects rather than standard DKA protocols 10, 9, 13.

References

Guideline

hyperglycemic crises in diabetes.

Diabetes Care, 2004

Research

How to work up an adult patient with metabolic acidosis.

British journal of hospital medicine (London, England : 2005), 2022

Research

[Metabolic acidosis].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2016

Related Questions

How should non‑anion‑gap metabolic acidosis be managed in a patient with type 1 diabetes mellitus?
In a 21‑year‑old patient with serum bicarbonate 16 mEq/L and a glucose of 96 mg/dL, how should the metabolic acidosis be evaluated and managed?
What is the appropriate management for a 71-year-old woman with type 2 diabetes, severe hyperglycemia (blood glucose 460 mg/dL), modest ketoacidosis (ketones 5.23 mmol/L, anion gap 20 mmol/L, bicarbonate 22 mmol/L, venous pH 7.35), high serum osmolarity (315 mOsm/kg), creatinine 0.99 mg/dL, eGFR 61 mL/min/1.73 m², history of pancreatitis and alcohol use, currently taking glipizide, and hemoglobin A1c 13.1%?
Should a 52-year-old woman with type 2 diabetes who was admitted for diabetic ketoacidosis, now has a closed anion gap, and is on metformin 850 mg twice daily plus basal insulin glargine 10 units daily, have her metformin dose increased, continue the current insulin regimen, or add a thiazolidinedione?
How can I evaluate for metabolic acidosis?
In an asymptomatic non‑diabetic adult with acute kidney injury and suspected complement‑mediated thrombotic microangiopathy who reports large carbohydrate‑rich meals, what is the significance of ketonuria and does it require specific treatment?
What is the appropriate management of an adverse reaction—including respiratory depression, anticholinergic toxicity, extrapyramidal symptoms, hypotension, or promethazine extravasation—in a patient receiving a pentazocine‑atropine‑promethazine combination?
Is foul-smelling stool associated with severe liver disease?
When should imeglimin be introduced in an adult with type 2 diabetes who has not achieved glycemic targets on metformin after three to six months or cannot tolerate metformin due to gastrointestinal side effects, contraindications such as impaired renal function (estimated glomerular filtration rate <45 mL/min/1.73 m²), active liver disease, or pregnancy?
Should a cardiac magnetic resonance imaging (MRI) be ordered for septal hypertrophy identified on echocardiography?
Can you interpret the chest radiograph and abdominal imaging for a 28‑year‑old patient with a persistent cough after emergency intubation, postoperative peripheral and abdominal edema, mast cell activation syndrome, liver and thyroid nodules, and ureteral stents?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.